Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...

Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock lately, despite its ...

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced that it has entered into a ...

Delving into the details, we found 53% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $373,316, and 7 were calls, valued ...

HIMS expands its tech-driven care with new diagnostics, hormonal treatments, and a Canada launch via Livewell.

Revenue of nearly $600 million, up 49% year-over-year in Q3 2025 Net income of nearly $16 million; Adjusted EBITDA of over $78 million in Q3 2025 Subscribers grew to almost 2.5 million, up 21% ...

Virtual healthcare and physician-focused digital platforms are reshaping U.S. healthcare delivery, with Hims & Hers Health, Inc. HIMS and Doximity, Inc. DOCS at the forefront. Hims & Hers operates a ...

Hims & Hers Health has sold off ~40% GLP-1 turbulence, but the core growth story remains intact. Read why HIMS stock is a ...

Shares of Hims & Hers are trending Thursday morning. The San Francisco-based telehealth company announced an international ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Hims & Hers Health, Inc. (HIMS) reports results for the quarter ended September 2025. While this widely-known ...

Hims & Hers Health recently reported strong year-over-year revenue growth but a steep earnings per share decline, shrinking margins, and higher operating expenses, while also authorizing a US$250 ...